Medicare Enrolled

Dr. Arjun Khosla, M.D.

Urology Physician · Broomall, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1974 SPROUL RD STE 106, Broomall, PA 19008
6102593000
In practice since 2008 (17 years)
NPI: 1851557573 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khosla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khosla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khosla

Dr. Arjun Khosla is an urology physician in Broomall, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Khosla performed 3,267 Medicare services across 2,067 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khosla received a total of $4,004 from 43 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khosla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 19% volume in PA $4,004 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,267
Medicare services
Top 19% in PA for urology physician
2,067
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~192 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
903 $9 $67
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
824 $2 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
670 $100 $295
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
238 $70 $208
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
222 $49 $85
Leuprolide acetate (for depot suspension), 7.5 mg 103 $137 $800
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
64 $63 $600
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $136 $358
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
44 $66 $298
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
29 $28 $100
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
27 $85 $246
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $43 $72
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
20 $146 $316
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
16 $105 $507
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
15 $94 $1,000
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
14 $345 $785
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
28.5% medium
70.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,004
Total received (2018-2024)
Avg $572/year across 7 years
Top 33% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,621 (90.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$383 (9.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$866
2023
$594
2022
$725
2021
$496
2020
$275
2019
$569
2018
$479

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$153
ABBVIE INC.
$149
Janssen Biotech, Inc.
$104
Axonics, Inc.
$88
AstraZeneca Pharmaceuticals LP
$77
Dendreon Pharmaceuticals LLC
$69
Astellas Pharma US Inc
$65
PROCEPT BioRobotics Corporation
$33
Novartis Pharmaceuticals Corporation
$31
Boston Scientific Corporation
$25
Telix Pharmaceuticals
$20
Tolmar, Inc.
$19
Ferring Pharmaceuticals Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$714
Janssen Biotech, Inc.
$522
Axonics, Inc.
$393
Myovant Sciences Inc.
$238
Sumitomo Pharma America, Inc.
$221
Dendreon Pharmaceuticals LLC
$182
ABBVIE INC.
$167
Teleflex LLC
$161
Ferring Pharmaceuticals Inc.
$133
PFIZER INC.
$128
Bayer HealthCare Pharmaceuticals Inc.
$106
Bayer Healthcare Pharmaceuticals Inc.
$82
AstraZeneca Pharmaceuticals LP
$77
UROVANT SCIENCES INC
$71
Clarus Therapeutics Inc.
$67
Blue Earth Diagnostics Limited
$66
Avadel Specialty Pharmaceuticals, LLC
$58
Boston Scientific Corporation
$46
Coloplast Corp
$35
Antares Pharma, Inc.
$34
PROCEPT BioRobotics Corporation
$33
Merck Sharp & Dohme LLC
$33
Kowa Pharmaceuticals America, Inc.
$32
Acerus Pharmaceuticals Corporation
$32
Merck Sharp & Dohme Corporation
$31
Novartis Pharmaceuticals Corporation
$31
Endo Pharmaceuticals Inc.
$29
Sun Pharmaceutical Industries Inc.
$27
NeoTract Inc.
$26
Baxter Healthcare
$22
TOLMAR Pharmaceuticals, Inc.
$21
BAXTER HEALTHCARE
$20
Telix Pharmaceuticals
$20
C. R. BARD, INC. & SUBSIDIARIES
$20
Tolmar, Inc.
$19
Amgen Inc.
$18
GENZYME CORPORATION
$18
MEDIVATION FIELD SOLUTIONS LLC
$15
Myriad Genetic Laboratories, Inc.
$14
Sagent Pharmaceuticals, Inc.
$13
AbbVie, Inc.
$12
Mission Pharmacal Company
$12
Aytu BioScience, Inc
$10
Top 3 companies account for 40.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLOSEAL · GEMTESA · Glydo · ILLUCCIX · JATENZO · JEVTANA · KEYTRUDA · LITHOVUE · LYNPARZA · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · POSLUMA · PROVENGE · Prolaris · Prolia · Rezum Generator · SEGLENTIS · SPEEDICATH · TISSEEL · UROLIFT · Uribel · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Broomall?
Compare urology physicians in the Broomall area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
294
Per 100K population
51.0
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
3.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khosla is a clinical cardiology specialist, with above-average Medicare volume (top 19% in PA), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khosla experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Khosla performed 903 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khosla receive payments from pharmaceutical companies?
Yes. Dr. Khosla received a total of $4,004 from 43 companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khosla's costs compare to other urology physicians in Broomall?
Dr. Khosla's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khosla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →